PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Research and Early Development, Respiratory & Immunology (R&I), AstraZeneca, Cambridge, U.K.\', \'Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton SO16 6YD, U.K.\', \'Biologics Safety Assessment, AstraZeneca, Gaithersburg, MD, U.S.A.\', \'Bioanalytical Sciences, AstraZeneca, Cambridge, U.K.\', \'Biologics Safety Assessment, AstraZeneca, Cambridge, U.K.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1042/CS20210713
?:doi
?:hasPublicationType
?:journal
  • Clinical science (London, England : 1979)
is ?:pmid of
?:pmid
?:pmid
  • 34778899
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Chronic pharmacological antagonism of the GM-CSF receptor in mice does not replicate the pulmonary alveolar proteinosis phenotype but does alter lung surfactant turnover.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34778899>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34778899>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all